about
Differential effects of TNF (TNFSF2) and IFN-γ on intestinal epithelial cell morphogenesis and barrier function in three-dimensional cultureExome sequencing of senescence-accelerated mice (SAM) reveals deleterious mutations in degenerative disease-causing genes.Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: Data from ULTRA 1, 2, and 3.Role of the endothelium in inflammatory bowel diseases.Melatonin and ulcerative colitis: evidence, biological mechanisms, and future research.MiR-29a promotes intestinal epithelial apoptosis in ulcerative colitis by down-regulating Mcl-1Expression of Blimp-1 in dendritic cells modulates the innate inflammatory response in dextran sodium sulfate-induced colitisOrally Administered Enoxaparin Ameliorates Acute Colitis by Reducing Macrophage-Associated Inflammatory ResponsesEvaluation of Tumor Necrosis Factor Alpha Polymorphism Frequencies in Endometriosis.Novel transcriptional regulation of VEGF in inflammatory processesBardoxolone Methyl Prevents High-Fat Diet-Induced Colon Inflammation in Mice.Therapeutic strategies for the management of ulcerative colitis.VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164b therapy.Sleep, immunity and inflammation in gastrointestinal disorders.Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis.Adalimumab: a review of its use in the treatment of patients with ulcerative colitis.Biological therapy for ulcerative colitis.Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis.Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis.Infliximab in ulcerative colitis.Efficacy and safety of golimumab 52-week maintenance therapy in Japanese patients with moderate to severely active ulcerative colitis: a phase 3, double-blind, randomized, placebo-controlled study-(PURSUIT-J study).Altered chemokine signalling in endothelial progenitor cells from acute ulcerative colitis patients.Cellular and molecular mechanisms of intestinal fibrosis.Novel benzoxazole derivatives DCPAB and HPAB attenuate Th1 cell-mediated inflammation through T-bet suppression.Foeniculum vulgare essential oil ameliorates acetic acid-induced colitis in rats through the inhibition of NF-kB pathway.Effect of roxithromycin on mucosal damage, oxidative stress and pro-inflammatory markers in experimental model of colitis.Golimumab for moderate to severe ulcerative colitis.Homocysteine promotes intestinal fibrosis in rats with trinitrobenzene sulfonic acid-induced colitis.TNF-α inhibits SCF, ghrelin, and substance P expressions through the NF-κB pathway activation in interstitial cells of Cajal.Marine microalgae bioengineered Schizochytrium sp. meal hydrolysates inhibits acute inflammation.Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis
P2860
Q27329003-D37F01AB-D796-461B-B0C6-4B1D724EE5A0Q30455193-7DAAC83B-FC43-4919-9FF6-B14AF6006455Q30844786-E493A4BE-1689-47D1-92AC-26688328F4C2Q34579746-BE175563-2CC8-4468-8210-0D98D4F5D5A9Q34796036-F6555951-7676-4564-B5D9-6956206C2EB6Q35038487-6D607328-0C69-4429-AC12-6E077B749BDDQ35434989-77017B8D-38E1-485E-8298-8D481C381272Q35719599-CCA599C8-2C54-4BF6-91D3-A936D6A14B9BQ36351289-7FA71FA5-0506-46B4-BC29-1BA8ED894165Q36728178-9BA2E17C-C456-4E9A-AF66-08287EEE3233Q36756653-BBDEE25F-6F48-41A4-A2C7-C880C265BD17Q37318035-70DA3B77-B494-49C3-A02F-E7318430C64FQ37359869-04A15838-CFF8-465B-AD66-4781FADA3783Q37439889-7E13EF96-1C0C-41E1-8AF5-96A3BAED860EQ37585946-9849D40D-4501-4D5A-944D-529E2E2902C9Q38098468-36E22CA3-EAC2-4FA2-9798-66B6E1B693F6Q38262662-6A65A89A-163D-4BBE-8C13-F5F9294AD82BQ38794312-75F9D885-A99B-42C8-AA09-AA52F5A35072Q38818978-C3BF8670-E188-4FAB-A94E-995757387E24Q38892066-BD427394-D551-4D7B-A238-F743247EC48FQ41860347-BEE0E37E-E59E-4642-BA5D-B28810845F90Q42022217-625A7840-62AF-4200-B5B1-8E615C6F926FQ42074610-E303A1DD-D0CA-4187-BC7D-8B22A36A7FB4Q42252132-46D74BFF-6C6A-4FFC-915A-177DBB63A23CQ42323585-D9228E41-EEE5-4485-A1BA-A354E2D9360FQ47607083-33439933-2323-41A9-88C5-707AD915BE49Q49500932-490CE0D5-4DF9-44C7-90E9-7708E8A4E267Q50853856-F02B66A5-4389-48DA-8D0D-3C7EFFE6B472Q54462926-C9DEE9E4-6AE6-495D-BEBE-EC9750292348Q54979996-E3F4A7D7-FDD3-4373-8A19-BACBE6F262DBQ55516049-CBA8BB6D-8109-4C28-BAFB-2FBBF23C9214Q57815111-D16234F8-6E6E-4DA1-AA9A-FE7D4A5DB84B
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The role of TNFalpha in ulcerative colitis.
@en
type
label
The role of TNFalpha in ulcerative colitis.
@en
prefLabel
The role of TNFalpha in ulcerative colitis.
@en
P2860
P356
P1476
The role of TNFalpha in ulcerative colitis.
@en
P2093
Bruce E Sands
Gilaad G Kaplan
P2860
P304
P356
10.1177/0091270007301623
P577
2007-06-13T00:00:00Z